|
| 34478658 | Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. | Cell | 2021 |
| 32234521 | Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. | Cell | 2020 |
| 30815226 | Sexually dimorphic tumor suppression by small mitochondrial <i>Arf</i>. | Oncotarget | 2019 |
| 31831659 | Surprising regulation of cell cycle entry. | Science | 2019 |
| 30573629 | NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. | Science | 2018 |
| 30214680 | Acquired palbociclib resistance in KRAS-mutant lung cancer. | Oncotarget | 2018 |
| 29880921 | Mouse medulloblastoma driven by CRISPR activation of cellular Myc. | Sci Rep | 2018 |
| 28652370 | Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of <i>Arf</i> tumor suppressor-deficient mice. | Proc Natl Acad Sci U S A | 2017 |
| 28329683 | Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma. | Cell Rep | 2017 |
| 27959598 | A New Cell-Cycle Target in Cancer - Inhibiting Cyclin D-Dependent Kinases 4 and 6. | N Engl J Med | 2016 |
| 26658964 | Targeting CDK4 and CDK6: From Discovery to Therapy. | Cancer Discov | 2016 |
| 25499760 | Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL. | Blood | 2015 |
| 26105537 | Forging a signature of in vivo senescence. | Nat Rev Cancer | 2015 |
| 24710003 | Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine model. | Pharmacogenet Genomics | 2014 |
| 25128497 | CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. | Genes Dev | 2014 |
| 24567370 | Simultaneous gene editing by injection of mRNAs encoding transcription activator-like effector nucleases into mouse zygotes. | Mol Cell Biol | 2014 |
| 23178376 | Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia. | Exp Hematol | 2013 |
| 23487795 | Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells. | Proc Natl Acad Sci U S A | 2013 |
| 23153837 | How politics trumped peer review at Texas cancer institute. | BMJ | 2012 |
| 22960768 | Ink4-Arf locus in cancer and aging. | Wiley Interdiscip Rev Dev Biol | 2012 |
| 21263154 | Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia. | Blood | 2011 |
| 21811412 | Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells. | PLoS Genet | 2011 |
| 21427293 | Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies. | Blood | 2011 |
| 20009580 | Developmental strategies for evasion of Arf tumor suppression. | Cell Cycle | 2010 |
| 20516124 | Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. | Cancer Res | 2010 |
| 19147535 | Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma. | Mol Cancer Res | 2009 |
| 19759355 | Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia. | Blood | 2009 |
| 19339492 | Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice. | Proc Natl Acad Sci U S A | 2009 |
| 19494829 | Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. | EMBO J | 2009 |
| 18418387 | Hzf regulates adipogenesis through translational control of C/EBPalpha. | EMBO J | 2008 |
| 18948745 | Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. | Cell Cycle | 2008 |
| 19029828 | Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d. | Cell Cycle | 2008 |
| 19028987 | The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias. | Cold Spring Harb Symp Quant Biol | 2008 |
| 18574466 | BCR-ABL and CDKN2A: a dropped connection. | Nat Rev Cancer | 2008 |
| 18519632 | Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL. | Genes Dev | 2008 |
| 16968893 | Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis. | Blood | 2007 |
| 17761812 | Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia. | Genes Dev | 2007 |
| 17695724 | The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. | Adv Exp Med Biol | 2007 |
| 17363588 | Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors. | Cancer Res | 2007 |
| 16382142 | Hzf, a p53-responsive gene, regulates maintenance of the G2 phase checkpoint induced by DNA damage. | Mol Cell Biol | 2006 |
| 16713573 | Autophagy by ARF: a short story. | Mol Cell | 2006 |
| 16864777 | N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development. | Proc Natl Acad Sci U S A | 2006 |
| 16915296 | Divorcing ARF and p53: an unsettled case. | Nat Rev Cancer | 2006 |
| 16479172 | The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma. | Cell Cycle | 2006 |
| 16671360 | Ubiquitination of, and sumoylation by, the Arf tumor suppressor. | Isr Med Assoc J | 2006 |
| 16618932 | Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. | Proc Natl Acad Sci U S A | 2006 |
| 15601844 | Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. | Mol Cell Biol | 2005 |
| 16869746 | p53-Dependent and -independent functions of the Arf tumor suppressor. | Cold Spring Harb Symp Quant Biol | 2005 |
| 16205118 | Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. | Cell Cycle | 2005 |
| 16222716 | Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway. | Dev Dyn | 2005 |